52 results about "Vitreous opacity" patented technology

The invention discloses a lutein ester health care product for protecting eyesight. The lutein ester health care product is prepared by taking lutein ester as a main material, and adding any one or more materials including taurine, selenium, zinc, alpha-lipoic acid, docosahexaenoic acid (DHA), vitamin A, vitamin E, vitamin B1, vitamin B2 and bilberry extract, and pharmaceutically acceptable formulation accessories. The outstanding innovation of the invention is the implementation of the method for preparing a functional eye health care product with the lutein ester instead of lutein, so that the bioavailability, the stability and the health care effect of the product are improved, and production cost can be greatly reduced. The health care product can be prepared into common dosage forms, such as tablets, capsula, granules and soft capsules. The lutein ester health care product is mainly used for the treatment on diseases, such as myopia, amblyopia, hyperopia, presbyopia, cataract, vitreous opacity, retinal pigment degeneration, macular degeneration, asthenopia, and retinopathy caused by diabetes, and the like. The lutein ester health care product adopts a unique formulation of multiple constituents, measures and mechanisms, and has significant treatment effects and excellent social and economic benefits.

The invention discloses a xanthophyll compound preparation with a powerful eye-protecting effects, which is made from the following raw materials in a certain proportion: xanthophyll, cowberry extracts, taurine, beta-carotin, zeaxanthin and zinc gluconate, in addition with adjuvant materials, and is available in various common forms such as capsules, granules and oral liquids. The main indications of the xanthophyll compound preparation include asthenopia, myopia, amblyopia, hypermetropia, cataract, macular degeneration, vitreous opacity, retinitis pigmentosa and diabetic retinopathy. The xanthophyll compound preparation contains compound ingredients, has a significant curative effect and is very worthy to be promoted.

The invention relates to a cranberry extract eye ophthalmic preparation and a preparation method and uses thereof, and belongs to the technical field of eye ophthalmic preparations. The technical problem to be solved is to provide a cranberry extract eye ophthalmic preparation. The cranberry extract eye ophthalmic preparation comprises an active ingredient of cranberry extract. The cranberry extract eye ophthalmic preparation can effectively treat, prevent or alleviate cataract, glaucoma, vitreous opacity, macular degeneration, retinopathy, optic atrophy, keratitis, epiphora induced by wind, presbyopia, myopia, visual fatigue, blurred vision, conjunctival burn, conjunctivitis, corneal ulcer, palpebral ecgema, floaters or trachoma and other eye diseases. A novel preparation is provided for treating cataract, glaucoma, vitreous opacity, macular degeneration, retinopathy, optic atrophy, keratitis, epiphora induced by wind, presbyopia, myopia, visual fatigue, blurred vision, conjunctival burn, conjunctivitis, corneal ulcer, palpebral ecgema, floaters or trachoma and other eye diseases, and meets the strong demand of people for loving and protecting eyes.

A composition and method for treating dry-eye syndrome and symptoms of vitreous opacities in a host comprising the oral administration of a composition which contains a pharmacologically effective amount of essential fatty acids, polar phospholipids, vitamins, minerals and dietary supplements.

The invention discloses a traditional Chinese medicine formula of application for preventing ophthalmic diseases. According to the traditional Chinese medicine formula, the application comprises the following components by weight part: 50 to 75 weight parts of Chinese angelica, 15 to 35 weight parts of pearl powder, 1 to 2.5 parts of bear gall powder, 40 to 65 weight parts of mint, 35 to 50 weight parts of almond, 40 to 65 weight parts of aloe and 1 to 2 weight parts of borneol. By promoting the blood circulation, removing the blood stasis, improving the micro-circulation, stimulating the eye acupoints and dredging the channels, the traditional Chinese medicine formula can prevent and treat cataract, vitreous opacity, myopia, presbyopia and other common ophthalmic pathological changes, more particularly, according to the statistics, the effective rate of those with cataract within 5 years reaches 85%; the effective rate of those with vitreous opacity reaches 96%; the effective rate of those with myopia and presbyopia reaches 87% and 92% respectively; and the traditional Chinese medicine formula of the application is obviously effective in treating other ophthalmic diseases.

The invention provides a fuzziness automatic grading method based on a color eyeground image. The method extracts three kinds of features of multi-threshold blood vessel pixel number, enhancement mean value and local standard variance to describe the degree of eyeground fuzziness, and based on the feature extraction result, a decision tree is designed to realize the final grading of the eyeground image. As other lesions, such as vitreous opacity, exudate, etc. will exist in the same eyeground image at the same time, the extraction of eyeground features is seriously affected and the final diagnosis of cataract is further affected, resulting in greater errors. In view of lesions such as vitreous opacity, the invention provides a method for eliminating vitreous opacity. The algorithm is also suitable for eliminating influences of exudates and can be applied to clinical medicine about interference of non-cataract lesions on cataract diagnosis, so as to improve the correct rate of diagnosis, to eliminate excessive errors and to provide the probability for large data screening and telemedicine. The method has a certain commercial value and an application value.

The invention discloses a medicament for improving eyesight. In the medicament, szechuan tangshen root, astragalus, large-headed atractylodes, Chinese angelica, rehmanniae vaporata, red paneoy root, rehmanniae praeparatum, gardenia fruit, medlar, eucommia bark, south dodder seed, raspberry, root of red-rooted salvia, notoginseng root, pale butterflybush flower, blackend swallowwort root, fish poison yarn and chrysanthemum are ground into 200-mesh powder, and are mixed uniformly, sterilized and packaged, wherein each bag contains 5 grams of medicament. The medicament is mainly used for treating patients who suffer from blurred vision caused by symptoms such as deficiency in kidney and yang, deficiency in blood and qi, diabetes mellitus, retinopathy, fundus hemorrhage, vitreous opacity, glaucoma or optic nerve pathological changes and the like, and 50 patients who suffer from the blurred vision are selected in the outpatient service of a hospital randomly to take the medicament. In the administration method and dosage, adults take twice every day, and takes 5 grams every time; for the children, the dosage is reduced by half; and 20 days is one treatment course, the total cure rate is 69 percent, the total cure rate of two treatment courses is 86.3, and the cure rate of three treatment course is 97.2 percent.

The invention relates to a Chinese medicament for treating cataract and glaucoma. The invention adopts the technical proposal that the medicament is prepared from the following raw materials by weight portion: 10 to 30 portions of cassia seed, 10 to 30 portions of dodder, 10 to 30 portions of angelica dahurica, 10 to 30 portions of magnetite, 5 to 15 portions of broom cypress fruit, 5 to 15 portions of bat faece, 30 to 50 portions of medicated leaven, and 30 to 50 portions of bamboo leaves. A preparation method comprises the following steps: crushing the magnetite and the bat faece according to the proportion, and sieving the crushed magnetite and bat faece by a sieve of 100 meshes; adding the cassia seed, the dodder, the angelica dahurica, the broom cypress fruit, the medicated leaven and the medicated leaven into a container, adding 8 times of water accounting for the total weight of the six gouts of Chinese medicament into the container, extracting the mixture for 1.5 to 2.5 hours, filtering the mixture, and taking medicinal liquid; adding 6 times of water into the rest residue, extracting the residue for 1 to 2 hours, filtering the residue, and taking the medicinal liquid; combining the twice medicinal liquids, condensing the medicinal liquid, drying the medicinal liquid in vacuum, and crushing the dried substance; and evenly mixing the dried substance and the crushed magnetite and bat faece. The Chinese medicament has good treatment effect on eye diseases such as cataract, glaucoma, vitreous opacity, floaters symptom, and the like.

The invention relates to a multi-dimensional xanthophyll preparation for powerfully protecting eyesight, which is prepared from raw materials consisting of xanthophyll, taurine, selenium, alpha-lipoic acid, L-ascorbic acid, beta-carotene, DHEA, a grape seed extract and pyridoxine hydrochloride and auxiliary materials in a certain proportion. The preparation can be prepared into tablets, capsules, granules, oral liquid, pills and other common formulations. The preparation is mainly used for myopia, amblyopia, hyperopia, presbyopia, cataract, vitreous opacity, retinitis pigmentosa, macular degeneration, asthenopia, diabetic retinopathy and the like. The preparation adopts a multi-component, multi-path and multi-mechanism unique formula and has obvious treatment effect and positive popularization value.

The invention relates to a traditional Chinese medicine composition for treating cataract, a prepration method thereof and a quality control method. The traditional Chinese medicine composition is composed of dendrobium, bitter orange, dwarf lilyturf tuber, baical skullcap root, cassia seed, liquoric root, cochinchnese asparagus root, twotooth achyranthes root, south dodder seed and other pharmaceutical raw materials, and excipients are added according to the conventional process to prepare tablets, capsules, dropping pills, pills, granules and other clinically acceptable formulations. The quality control method of the traditional Chinese medicine composition comprises the TLC identification of the dwarf lilyturf tuber, the south dodder seed and the Chinese magnoliavine fruit and the content measurement of baicalin in the baical skullcap root, and the method can effectively control the drug quality and ensure the efficacy of the drug. The drug has the effects of nourishing liver and kidney, benefiting qi and improving eyesight and has good effects for minute cataract, vision loss, mydriasis and senile cataract, impaired vision due to vitreous opacity, blowing in the wind and other symptoms.

The invention discloses an axis oculi length measuring device and an axis oculi length measuring method. The axis oculi length measuring device comprises a light source, a spectroscopical module, a reference arm module, a sample arm module and a detection module. According to the axis oculi length measuring device disclosed by the invention, measurement of axis oculi length is realized through thenature of OCT, and the disadvantage that an optical related biomeasuring instrument easily measures a patient suffering from vitreous opacity wrongly is overcome; one beam of detection light is separated into two beams of detection light through a sample arm, the two beams of the detection light are respectively focused on a cornea and a retina for simultaneous scanning, and images are simultaneously obtained; the optical axes of the two beams of the detection light are coaxial, so that the measuring result is free from the influence of eye movement; for the patient suffering from vitreous opacity, the light penetrating power of eyes is weakened, but final measuring accuracy cannot be influenced; and besides, the measuring method provided by the invention combines equipment for measuringaxis oculi length with OCT equipment, so that the situation that which layer of the retina the specific measuring position on the retina is located on can be more intuitively seen.

The invention discloses a method for processing a condensed pill for treating eye disease. Medicinal prescription of 3000 condensed pills comprises the following components of 10-15g of pearl powder from bred mussels, 15-20g of cloud notoginseng powder, 5-10g of fructus viticis, 8-10g of selfheal spike, 8-10g of angelica sinensis, 5-10g of ligusticum wallichii and the like. The product pill is prepared by the processes of decocting crude drugs, crushing raw materials, refining old honey and the like. The vision of a sufferer can be effectively improved; muscae volitantes and clumps ghosting of the affected eye caused by vitreous opacities can be removed; middle concurrency cataracts caused by lens opaque can be effectively reversed; bulbi hypertonia of the affected eye caused by secondary glaucoma can be reversely reduced to within a normal value of 10-21mmHg; and the pain of the sufferer during extraction eyeball by a western medicine surgery is removed. Therefore, the medical problem that difficult eye diseases cannot be solved by western medicine at present is overcome.

The present invention relates to a traditional Chinese medicine for treating eye diseases, in particular to a traditional Chinese medicine preparation for treating retinal hemorrhage and vitreous opacity. The present invention is composed of the pharmaceutical raw materials with the following parts by weight: danshen root 30, kudzuvine root 15, cassia seed 15, south dodder seed 15, cattail pollen 10, swordlike atractylodes rhizome 10, seaweed 10, kelp 10, baical skullcap root 6 and sanchi powder 2. Compared with the former obtained patent ZL03104746.7 by the applicant, the prescription composition of the present invention eliminates three traditional Chinese medicines of sea-ear shell, nacre and medicinal cyathula root, increases one medicine of kudzuvine root and adjusts the parts by weight of all the traditional Chinese medicines in the prescription composition. The modern pharmacological studies show that the puerarin contains flavonoids, which can improve the microcirculation, enhance the red cell deformability, reduce the aggregation, improves the blood flow, increase the local microcirculation blood flow and inhibit the platelet aggregation. Therefore, the prescription composition of the medicine is more scientific and reasonable; and the efficacy is more significant through the clinical observations in the past four years.

The invention provides a health food conditioner capable of reliving stagnancy of qi and blood stasis. The health food conditioner contains kudzu root, safflower, cowberry, peack seeds, celery seeds, hawthorn and lophatherum; furthermore, the composition proportion of the cowberry meal, kudzu root meal, safflower meal, peack seed meal, celery seed meal, hawthorn meal and lophatherum meal is 1:1:2:1:2:2:1. The invention also provides a method for preparing the health food conditioner capable of reliving stagnancy of qi and blood stasis. The formula is simple; main ingredients are prepared from concentrated food meal and are good in taste; through regulating the function of a blood circulation system, so that the health food conditioner is capable of effectively improving the stagnancy of qi and blood stasis symptoms, improving the blood pressure, skin color, blood glucose, blood fat, sleep, vitreous opacity, irregular menstruation and blood viscosity.

According to the MDP-net-based vitreous opacity grading screening method and device, a crystalline lens, a quasi-trapezoidal vitreous cavity and a turbid focus area in an eye vitreous ultrasonic image can be segmented through deep learning by an eye vitreous ultrasonic image adaptive segmentation model and a severity classification algorithm; according to the method, the vitreous opacity severity of the patient can be quickly and accurately judged and screened after image training by applying the deep learning technology, and the obtained result is quick, objective, accurate and stable.

The invention discloses an eye drops and preparing method to treat cataract for person in middle and old age and vitreous opacity, which is made of sulfur puluonin and corresponding auxiliary materials. The invention has relatively stable quality and effect to be carried and intaked safely and heathly, which improves the quality standard and enlarges the drug kinds to satisfy the need of the people for drugs.

The invention relates to a Chinese medicine preparation for treating cataract, which is characterized in that the Chinese medicine preparation is prepared by the following raw material drugs by weight: 6-10g of pollen, 8-10g of astragalus root, 8-10g of yam, 3-5g of cornu antelopis, 10-20g of ginseng, 8-10g of sinomenium acutum, 8-10g of concha hallotidis, 10-20g of fructus broussonetiae, 6-10g of cassia occidentalis, 6-10g of Chinese gentian, 10-20g of pearl, 8-10g of loganin, 8-10g of tribulus terrestris and 6-10g of bupleurum root, and the raw material drugs are crushed and evenly mixed, pass a 80-mesh sieve and are put into capsules. The Chinese medicine preparation for treating cataract has good functions of anti-logging improving eyesight, blood stasis and hemostasis, liver calming, fever reducing, and the like, and has good treating effect for early cataract and vitreous opacity. Clinically, more than 1,000 patients are dialectically treated by the Chinese medicine preparation, the Chinese medicine preparation has better treating effect, and the effective rate can reach more than 92%.

The invention discloses a pharmaceutical composition for treating vitreous opacity and a preparation method thereof, and the pharmaceutical composition is prepared from raw material medicines of Fibroferrite, Plagiogyria distinctissima, beta-hederin, common anotis herb and Crateva unilocularis, can be made into various dosage forms according to conventional preparation processes, and has significant effect for treating of vitreous opacity.

The invention discloses a pharmaceutical composition for treating vitreous opacity and a preparation method of the pharmaceutical composition. The pharmaceutical composition is prepared from the raw material medicines including eucalyptus fruits, common anotis herb, hederagenin, glepidotin C and saikoside in proportion, can be prepared into various dose forms by virtue of conventional preparation processes and has a remarkable effect to the treatment of the vitreous opacity.

The invention discloses a method for processing a condensed pill for treating eye disease. Medicinal prescription of 3000 condensed pills comprises the following components of 10-15g of pearl powder from bred mussels, 15-20g of cloud notoginseng powder, 5-10g of fructus viticis, 8-10g of selfheal spike, 8-10g of angelica sinensis, 5-10g of ligusticum wallichii and the like. The product pill is prepared by the processes of decocting crude drugs, crushing raw materials, refining old honey and the like. The vision of a sufferer can be effectively improved; muscae volitantes and clumps ghosting of the affected eye caused by vitreous opacities can be removed; middle concurrency cataracts caused by lens opaque can be effectively reversed; bulbi hypertonia of the affected eye caused by secondary glaucoma can be reversely reduced to within a normal value of 10-21mmHg; and the pain of the sufferer during extraction eyeball by a western medicine surgery is removed. Therefore, the medical problem that difficult eye diseases cannot be solved by western medicine at present is overcome.

The invention relates to a traditional Chinese medicinal compound for treating ophthalmology diseases, in particular for treating eye ground hemorrhage vitreous opacity, wherein the ingredients and weight proportions of the medicament are, radix salvia miltiorrhiza 12.86-19.29, sea-ear shell and Cassia occidentalis semen cassiae torae each 9.65-19.29, ruby mica 3.22-19.29, sea weed and sea apron each 3.86-7.72, notoginseng powder, cattail pollen, and baikal skullcap root each 1.93-6.43, doddor seed 6.43-9.65, cyathula root 3,86-9.65, atractylodes rhizome 3.22-6.43.

The invention belongs to a traditional Chinese medicine, specifically to a vitreous opacity and hemorrhage treatment traditional Chinese medicine, which is characterized by comprising, by weight, 10-20 g of rehmannia glutinosa libosch, 5-15 g of cornus officinalis, 5-15 g of cortex moutan, and 5-15 g of tuckahoe, wherein the selected rehmannia glutinosa libosch, the selected cornus officinalis, the selected cortex moutan and the selected tuckahoe are washed, are subjected to air-drying, and are grinded into fine powder with a particle size of 100 mesh, and the one part of the obtained drug powder is directly and orally taken twice a day. According to the present invention, based on the Chinese medical science syndrome differentiation theory, characteristics of simple formula, easily available materials, low cost, high treatment effect, no toxic-side effect and effective vitreous opacity and hemorrhage treatment are provided.

The invention relates to eyesight improving health medicines, and specifically relates to a traditional Chinese medicine external use composition for eliminating vitreous opacities and capable of tonifying the liver and kidney, activating blood circulation to dissipate blood stasis, clearing internal heat and improving eyesight, and a preparation method thereof. The materials of the composition include magnetite, field thistle herb, belvedere fruit, palmleaf raspberry fruit, cattail pollen, turmeric and borneol; an eye patch liquid medicine can be prepared through vacuum concentration; an eyepatch can be prepared after non-woven fabrics are soaked in the eye patch liquid medicine; and eye ointment can be prepared through vacuum concentration. The composition is convenient in usage, has the effects of tonifying the liver and kidney, activating blood circulation to dissipate blood stasis, clearing internal heat and improving eyesight, and has significant curative effects of treating vitreous opacities through external use.

A composition and method for treating dry-eye syndrome and symptoms of vitreous opacities in a host comprising the oral administration of a composition which contains a pharmacologically effective amount of essential fatty acids, polar phospholipids, vitamins, minerals and dietary supplements.

The invention discloses a medicinal decoction for treating vitreous opacities and fundus hemorrhage and a preparation method. The medicinal decoction comprises the following components in parts by mass: 1 to 3 parts of rhizome of rehmannia, 1 to 3 parts of cornus officinalis, 1 to 3 parts of cortex moutan, 1 to 3 parts of rhizoma alismatis, 1 to 3 parts of wolfiporia extensa, 1 to 3 parts of astragali complanati semen, 1 to 3 parts of plantain seeds, 1 to 3 parts of medlar, 1 to 3 parts of dendrobium nobile, 1 to 3 parts of Chinese thorowax roots, 1 to 3 parts of scutellaria baicalensis, 1 to 3 parts of green tangerine peel, 1 to 3 parts of radix aucklandiae, 1 to 3 parts of motherwort fruits and 1 to 3 parts of raw licorice. The preparation method for the medicinal decoction comprises the steps of selecting first-grade rhizome of rehmannia, cornus officinalis, cortex moutan, rhizoma alismatis, wolfiporia extensa, astragali complanati semen, plantain seeds, medlar, dendrobium nobile, Chinese thorowax roots, scutellaria baicalensis, green tangerine peel, radix aucklandiae, motherwort fruits and raw licorice, removing residual impurities from the components except the plantain seeds which are additionally packaged, for later use; loading the medicaments in a cloth bag, closing an opening of the cloth bag, impregnating the medicaments for half an hour in cooled boiled water, loading the impregnated medicaments in a decocting machine, injecting cooled boiled water which is sufficient to impregnate the medicaments by 5 centimeters, performing primary decoction for 35 minutes, filtering liquid medicine, adding slightly warm boiled water, performing secondary decoction for 25 minutes, and mixing and concentrating the liquid medicine to obtain 1,620 milliliters of 50 percent traditional Chinese liquid medicine.

The present invention discloses a Chinese patent medicine for curing ophthalmopathies of various cataracts and external oculopathy and other diseases of vitreous opacity and pain of eye. Said medicine is a powder preparation transnasal administration, and its effective rate is 100%. Said medicine is made up by using ephedra root, Chinese angelica root and musk through a certain preparation process.

The invention discloses eyedrops prepared from Noni flowers and fruits, N-acetyl carnosine and hyaluronic acid. The eyedrops are used for preventing and treating vitreous body and crystalline lens opacity degeneration and xerophthalmia and prepared from, by weight, 25-45 parts of Noni flowers, 32-44 parts of Noni fruits, 16.5-20.5 parts of herba erigerontis, 15-20 parts of N-acetyl carnosine, 6-12 parts of active hyaluronic acid, 6-18 parts of natural vitamin, 1.5-2.5 parts of borneol, 2-3 parts of pearls and 10-12 parts of distilled water. In this way, the eyedrops prepared from Noni flowers and fruits, N-acetyl carnosine and hyaluronic acid contain no preservative, have no toxic or side effect, have no stimulation on eyeballs, can relieve eye fatigue, are used for preventing and treating vitreous opacity, crystalline lens opacity and xerophthalmia, have the good treatment effect on various fundi diseases, and are remarkable in treatment effect and high in safety performance.

The invention relates to the technical field of traditional Chinese medicines, and discloses a traditional Chinese medicine for effectively treating insomnia and a decoction method. The traditional Chinese medicine is prepared from the following components in parts by weight: 18-36 parts of antelope's horns, 12-24 parts of bear galls, 15-20 parts of pearl, 6-12 parts of ginseng, 15-20 parts of caltrop, 10-20 parts of glossy privet fruit, 10-20 parts of chrysanthemum, 20-30 parts of dendrobe, 10-20 parts of equisetum hyemale, 10-20 parts of dogwood, 10-20 parts of cuscuta chinensis and 9-17 parts of lycium barbarum. The traditional Chinese medicine is capable of effectively treating eye diseases such as glaucoma, cataract, vitreous opacity, fundus hemorrhage, optic atrophy, conjunctivitis, keratitis, iritis, epiphora induced by wind, juvenile myopia, hyperopia and amblyopia.

The invention relates to a traditional Chinese medicine composition for treating cataract, a prepration method thereof and a quality control method. The traditional Chinese medicine composition is composed of dendrobium, bitter orange, dwarf lilyturf tuber, baical skullcap root, cassia seed, liquoric root, cochinchnese asparagus root, twotooth achyranthes root, south dodder seed and other pharmaceutical raw materials, and excipients are added according to the conventional process to prepare tablets, capsules, dropping pills, pills, granules and other clinically acceptable formulations. The quality control method of the traditional Chinese medicine composition comprises the TLC identification of the dwarf lilyturf tuber, the south dodder seed and the Chinese magnoliavine fruit and the content measurement of baicalin in the baical skullcap root, and the method can effectively control the drug quality and ensure the efficacy of the drug. The drug has the effects of nourishing liver and kidney, benefiting qi and improving eyesight and has good effects for minute cataract, vision loss, mydriasis and senile cataract, impaired vision due to vitreous opacity, blowing in the wind and othersymptoms.

The invention provides a medicine for treating vitreous opacity and a preparation method thereof. The medicine is prepared from radix codonopsis, concha haliotidis, herba ecliptae, radix rehmanniae preparata, spina date seeds, radix angelicae sinensis, radix astragali seu hedysari, fructus lycii, flos buddlejae, flos chrysanthemi, rhizoma dioscoreae, seeds of feather cockscomb, radix paeoniae alba, rhizoma chuanxiong, radix gentianae, bat's dung, semen coicis, pericarpium citri reticulatae, poria cocos, radix paeoniae rubra, motherwort fruits and fructus corni according to the certain weight matching. The medicine has the functions of calming the liver and suppressing yang, relieving rheumatic plains and cooling the blood, tonifying the kidneys and benefiting yin, promoting blood circulation to restore menstrual flow and inducing mild diaphoresis and dissipating heat, and is used for treating the vitreous opacity, the medicine becomes effectively rapidly, the efficacy is good, and thevitreous opacity is not liable to recur.